Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950137-06-003139
Filing Date
2006-03-16
Accepted
2006-03-16 14:03:48
Documents
11
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a18525e10vk.htm 10-K 1179594
2 EXHIBIT 10.28 a18525exv10w28.txt EX-10.28 137012
3 EXHIBIT 10.29 a18525exv10w29.txt EX-10.29 5666
4 EXHIBIT 10.30 a18525exv10w30.txt EX-10.30 41558
5 EXHIBIT 10.31 a18525exv10w31.txt EX-10.31 20037
6 EXHIBIT 10.32 a18525exv10w32.txt EX-10.32 7054
7 EXHIBIT 21 a18525exv21.htm EX-21 5370
8 EXHIBIT 23 a18525exv23.htm EX-23 1437
9 EXHIBIT 31.1 a18525exv31w1.htm EX-31.1 6606
10 EXHIBIT 31.2 a18525exv31w2.htm EX-31.2 6617
11 EXHIBIT 32.1 a18525exv32w1.htm EX-32.1 4786
  Complete submission text file 0000950137-06-003139.txt   1417332
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
VALEANT PHARMACEUTICALS INTERNATIONAL (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-11397 | Film No.: 06691168
SIC: 2834 Pharmaceutical Preparations